A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
about
Clinical features and outcome of mucormycosisInvasive mold infections in solid organ transplant recipientsRecent developments in the management of invasive fungal infections in patients with oncohematological diseasesIsavuconazole: A New Broad-Spectrum Triazole Antifungal AgentAdaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibilityGene expansion shapes genome architecture in the human pathogen Lichtheimia corymbifera: an evolutionary genomics analysis in the ancient terrestrial mucorales (Mucoromycotina)Biology, systematics, and clinical manifestations of Zygomycota infectionsMucormycosis in Iran: a systematic review.[Clinical and radiological aspects of mucormycosis].Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.Population-based analysis of invasive fungal infections, France, 2001-2010.Construction of a Recyclable Genetic Marker and Serial Gene Deletions in the Human Pathogenic Mucorales Mucor circinelloides.Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphoterRisk factors associated with invasive fungal infections in combat trauma.Effect of early screening for invasive fungal infections in U.S. service members with explosive blast injuries.Lichtheimia species exhibit differences in virulence potential.Mucor irregularis-associated cutaneous mucormycosis: Case report and review.Human Fungal Pathogens of Mucorales and Entomophthorales.Effective treatment of cerebral mucormycosis associated with brain surgeryThe genome sequence of four isolates from the family LichtheimiaceaeImpact of Mucorales and Other Invasive Molds on Clinical Outcomes of Polymicrobial Traumatic Wound Infections.Environmental Factors Related to Fungal Wound Contamination after Combat Trauma in Afghanistan, 2009-2011.Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report.Ex vivo confocal microscopy: a new diagnostic technique for mucormycosis.Histopathological techniques for the diagnosis of combat-related invasive fungal wound infections.Posttraumatic mucormycosis: a nationwide study in France and review of the literature.Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registriesPopulation pharmacokinetics of conventional and intermittent dosing of liposomal amphotericin B in adults: a first critical step for rational design of innovative regimensPrevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016).Early Complications and Outcomes in Combat Injury-Related Invasive Fungal Wound Infections: A Case-Control Analysis.Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold InfectionsEfficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Successful treatment of disseminated mucormycosis in a neutropenic patient with T-cell acute lymphoblastic leukaemiaCombat trauma-associated invasive fungal wound infections: epidemiology and clinical classification.Mucormycosis in two community hospitals and the role of infectious disease consultation: a case series.Risk factors for mortality in patients with invasive mucormycosis
P2860
Q24563512-416DCC82-32AE-476D-9E2B-B4D946E0CDB0Q26823811-D0228D53-9203-407C-B4F0-AB90CF66C996Q28077381-C0D4D40F-39E4-4B19-8629-CD950085935AQ28082019-B5899E7E-972B-4B16-ADEB-27C9043100A9Q28606369-7B5B0BB4-0601-4DF5-8861-91F93C0E70DBQ28654542-A32009C5-E53E-42CE-BAE2-2D1F5C88F213Q28656453-FEB6BB0E-9EBC-4F20-A18F-1E08202AA6E4Q30251882-82D14281-EB93-41CC-B47A-7555B91B9E5CQ30603777-C31AB006-D80C-4B8B-80B7-FE74EA66A37FQ30873926-A00029AC-294B-40CB-9799-7C1AB762FFFCQ31111038-E390E1FD-BD96-4DD8-9D36-D3AC1C73EAE8Q33773267-B23954CB-9ECD-44EC-A2E3-140220B921F7Q33816423-659E23CB-3914-457C-BBA9-2D90C8B888A1Q33877277-A1E31324-A18B-4348-8CA5-1138012F7E4AQ34315804-97F371C8-7900-4D6C-BB48-B7D602CCA1F7Q34329954-3A874516-6D9D-4166-8BC9-14BC6A58B831Q34330154-089E8F94-DAB9-47B1-A136-8D0BB99B4CA6Q34387525-DFD5C11C-6B49-4B45-AE06-B8FE50B62CE1Q34436174-D37BFA52-E583-4980-A079-B298D3E377A6Q35245238-5B904D83-AA64-483A-8A3C-F52EFDA2BD57Q35449392-9F0CACC6-7BB6-46E7-98AE-F2C9497A0929Q35742773-B30B5641-2BB8-476A-9A7F-EB878C2B5FADQ35757575-46779DEE-B082-46EB-946F-D1E75CF45DE8Q35786379-2574CDD3-AD93-4877-9165-4647ADE7CBECQ35792845-27025BAF-F5B6-493D-A292-163994555E8DQ35823772-16B1B96E-9D54-47AB-A2FD-A58216A443FAQ36072391-92D7C377-6AAB-47D5-B199-36A0504E4570Q36150841-E6452D7C-5262-4010-A389-C858D25616CAQ36189107-BC875010-3886-4D7B-9D2C-D9B44F39530CQ36276870-339C0E29-B7F8-4E1B-8E50-CC556A93D1A7Q36353240-006443D2-BEC7-44A0-A7AC-4153B9E5A6F3Q36600289-CDE09DF5-3FB4-4C0F-9604-4DAB4E59472EQ36862446-486A6F45-B77D-43C0-A713-8AD301737C43Q36933186-A6B4BBEB-4BA9-4EB3-B96F-73D0C441A54EQ36969836-080FEB43-C72E-4300-813A-E293025E6F7CQ37041199-9899EF74-25EC-46B6-8A0D-87C68E36D076Q37077558-DAE6C879-9102-451E-8AC6-51C422322533Q37098651-EDAE2052-11CF-4B0F-B98D-CAF34BF3AD33Q37278607-252F41DE-F1B5-4968-A6A2-7FEEA994D483Q37359336-308EE806-EFF9-40B0-A367-FE9E3819A5CC
P2860
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
@en
type
label
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
@en
prefLabel
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
@en
P2093
P2860
P356
P1476
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007)
@en
P2093
D Garcia-Hermoso
F Lanternier
French Mycosis Study Group
O Lortholary
P2860
P304
P356
10.1093/CID/CIR880
P407
P478
54 Suppl 1
P577
2012-02-01T00:00:00Z